A/Prof Tee Lim
MBBS, FRANZCR, Radiation Oncologist
For patients/carers
For doctors
MBBS, FRANZCR, Radiation Oncologist
Locations
Clinical interests
- Genitourinary cancer
- Breast cancer
- Lung cancer
- Metastatic cancer
- Gastrointestinal cancer
- Lymphoma
- Brain and central nervous system
- Skin cancer
- Bone cancer
Treatment techniques
- Radiation oncology
Languages
Fluent
- English
- Cantonese / 廣東話
- Mandarin / 普通话
- Hokkien
- Malay / Melayu
Biography
Clinical interests in breast, urological, gastrointestinal (GI), and lung cancers.
Tee completed his undergraduate medical degree at Monash University in Melbourne. He moved to Western Australia to continue medical and then specialist training in radiation oncology, and became a fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR) in 2005. After completing a clinical fellowship at Perth Radiation Oncology, Tee went on to complete a further clinical research fellowship in genitourinary oncology, and specific treatment techniques at Sunnybrook's Odette Cancer Centre (Toronto, Canada), the University of California, San Francisco Medical Centre, and the Seattle Prostate Institute.
He has written or been an investigator in nine published papers and 13 abstracts, is actively involved in clinical trials, and regularly presents at scientific meetings.
Did you know?
Tee is a keen sportsman. Whether it’s watching or playing sport, he’s usually involved. He loves to travel and explore culturally interesting destinations when on holiday with his wife and two children.
More information
Tee works primarily across breast, gastro-intestinal, genitourinary and thoracic cancers. He has an interest in radiation therapy treatments to support cardiac transplant and cardiology patients, including a collaboration with the cardiology team at Fiona Stanley Hospital in Perth. Dr Ben King and Tee treated the first patient with refractory ventricular tachycardia with stereotactic cardiac ablative radiation therapy in Western Australia in July 2020.
- Royal Australian and New Zealand College of Radiologists (RANZCR)
- Trans Tasman Radiation Oncology Group (TROG)
- American Society for Radiation Oncology (ASTRO)
- European Society for Radiotherapy and Oncology (ESTRO)
- Australasian Gastro-Intestinal Trials Group (AGITG)
- ALCG
- Lee, F., Fazackerley, B. C., Lim, T. S., D'Orsogna, L., Downing, J., Truong, L., ... & Dembo, L. (2025). Novel, short-course, low-dose total lymphoid irradiation (TLI) post heart transplant for recalcitrant rejection–A single centre experience. Transplant Immunology, 102333.
- Lee, S. F., Choong, E. S., Leung, J., Lim, T., Ramani, S., Lim Boon, D., Macleod, C., Tomaszewski, J. M., Tey, J. C. S., Foroudi, F., & Chao, M. (2025). Study protocol: Feasibility and safety of conventional external-beam radiotherapy with an integrated stereotactic lite gross-tumour-volume boost for painful bone metastases: The HYBRID study. npj Digital Medicine 2025.
- Lee, S. F., Choong, E. S., Leung, J., Lim, T., Ramani, S., Lim Boon, D., Macleod, C., Tomaszewski, J. M., Tey, J. C. S., Foroudi, F., & Chao, M. (2025). Study protocol: Feasibility and safety of conventional external-beam radiotherapy with an integrated stereotactic lite gross-tumour-volume boost for painful bone metastases: The HYBRID study. Radiation Oncology, 20(1), 150.
- Das, S. K., Ryan, T., Panettieri, V., Hawson, J., Lim, T., Hardcastle, N., Chang, D., Goodall, S. K., Anderson, R. D., Kalman, J., Siva, S., King, B. J., & Lee, G. (2025). Stereotactic arrhythmia radioablation (STAR) for refractory ventricular tachycardia: The initial Australian experience. Heart Rhythm, 22(8), 364–373.
- Kneebone, A., Fraser-Browne, C., Duchesne, G. M., Fisher, R., Frydenberg, M., Herschtal, A., Williams, S. G., Brown, C., Delprado, W., Haworth, A., Joseph, D. J., Martin, J. M., Matthews, J. H. L., Millar, J. L., Sidhom, M., Spry, N., Tang, C. I., Turner, S., Wiltshire, K. L., Woo, H. H., Davis, I. D., Lim, T. S., & Pearse, M. (2020). Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): A randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology, 21(10), 1331–1340. https://doi.org/10.1016/S1470-2045(20)30456-3
- Emery, J. D., Doorey, J., Jefford, M., King, M., Pirotta, M., Hayne, D., Martin, A., Trevena, L., Lim, T., Constable, R., Hawks, C., Hyatt, A., Hamid, A., Violet, J., Gill, S., Frydenberg, M., & Schofield, P. (2016). The ProCare trial: A phase II randomised controlled trial of shared care for follow-up of men with prostate cancer. BJUI Open.
- Ung, N. M., Wee, L., Hackett, S., Jones, A., Lim, T. S., & Harper, C. H. (2013). Comparison of low-dose, half-rotation, cone-beam CT with electronic portal imaging device for registration of fiducial markers during prostate radiotherapy. Journal of Applied Clinical Medical Physics, 14(4), 4249. https://doi.org/10.1120/jacmp.v14i4.4249
- Lim, T. S., Cheung, P., Loblaw, A., et al. (2008). Hypofractionated accelerated radiation therapy using a concomitant intensity-modulated radiotherapy boost technique for localised high-risk prostate cancer: Acute toxicity results. International Journal of Radiation Oncology, Biology, Physics, 72(1), 85–92.
- Lim, T. S., O’Driscoll, G., Freund, J., Petersen, V., & Heywood, J. (2007). Total lymphoid irradiation for refractory allograft cardiac transplant rejection. The Journal of Heart and Lung Transplantation, 26(12), 1249–1254. https://doi.org/10.1016/j.healun.2007.09.013
- Lim, T. S., Petersen, V., & Zissiadis, Y. (2007). Computed tomography planning for breast cancer. Australasian Radiology, 51(3), 289–295. https://doi.org/10.1111/j.1440-1673.2007.01786.x
Outside of work, A/Prof Lim enjoys sport, entertainment, travelling, and spending quality time with his family.
Explore more
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.